Sarcopenia and Cachexia in Patients With Lung Cancer

Enrolling by invitation

Conditions studied: Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

In brief

The PHILICA study investigates whether muscle mass, muscle strength, and muscle function are associated with treatment tolerance, quality of life and survival in patients with lung cancer. It also aims to explore why some patients face challenges in completing their treatment. The findings may contribute to improved strategies for supporting patients and developing more precise and individualized treatment plans in the future.

Key facts

Study ID

NCT06730685

Run by

Zealand University Hospital

People needed

160

Starts

2024-12-12

Expected to finish

2028-04-01

Last updated by the study team

2026-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years of age
• Diagnosed with lung cancer (all types and stages) and scheduled for oncological treatment
• More than 3 months expected survival

You may not qualify if…

• Competing cancer
• Pregnancy
• Severe physical or cognitive disabilities preventing physical testing and informend consent
• Not able to read and understand Danish

Where it is running

• Zealand University Hospital — Næstved, Region Sjælland, Denmark

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.